SESamah Abd Elhamid

Samah Abd Elhamid

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Samah Abd Elhamid has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Value of hematological indices versus VEGF as biomarkers of activity in Behçet’s disease

    by T. A. Gheita, B. R. Sakr, R. E. Rabea, S. M. Abd ElHamid

    The aim of this study is to investigate the value of several hematological indices, neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio (PLR), red blood cell distribution width (RDW), and mean platelet volume (MPV), versus vascular endothelial growth factor (VEGF) as biomarkers of activity in Behçet’s disease (BD).


  • Open Access

    Risk index for early infections following living donor liver transplantation

    by Shaimaa Elkholy, Doaa Ahmed Mansour, SamahAbd El-Hamid, Ula M. Al-Jarhi, Saeed M. El-Nahaas, Sherif Mogawer

    Introduction Post-operative infections in patients undergoing living donor liver transplantation (LDLT) are a major cause of morbidity and mortality. This study aims to develop a practical and efficient prognostic index for early identification and possible prediction of post-transplant...


  • Open Access

    Comparing D-dimer status in children with familial Mediterranean fever during and in between acute attacks

    by Samia Salah, Hala Salah Talaat, Noussa Ragab El Basha, Huda Marzouk, Samah Abd Elhamid, Eman Shafik Shafie


  • Therapeutic efficacy of human umbilical cord mesenchymal stem cells transplantation against renal ischemia/reperfusion injury in rats

    by Sohair R. Fahmy, Amel M. Soliman, Mervat El Ansary, Samah Abd Elhamid, Heba Mohsen


  • Significance of CD99 expression in T-lineage acute lymphoblastic leukemia

    by Azza A. Aboul Enein, Hala A. Abdel Rahman, Nahla El Sharkawy, Samah Abd Elhamid, Sonia M.A. Abbas, Rafaat Abdelfaatah, Mohamed Khalil, Lamiaa A. Fathalla

    BACKGROUND: CD99 was first isolated as an antigen on the T acute lymphoblastic leukemia cells. It has been shown to participate in T cell adhesion and is widely expressed on a variety of hematopoietic and non-hematopoietic cell types. CD99 was first


  • Prevalence of polyoma BK virus infection among living‐donor renal transplant recipients

    by M. El Ansary, S. Abd Elhamid, G. Saadi, W. Ismail, N. Ibrahim, N. Bahaa El‐Din, S. Alhsyek

    Background: Polyomavirus nephropathy (PVN) mainly caused by BK polyomavirus (BKPyV) remains the most common productive viral infection of the kidney in immunosuppressed patients. The diagnosis of PVN is based on the detection of BK viruria and BK viremia in conjunction with histological findings in the graft biopsy.Methods: Our study was aimed to estimate the prevalence of productive BKPyV infection among renal transplant patients within the first year post‐transplant and identify those at risk of developing PVN. Our cross‐sectional study was conducted on 134 kidney transplant patients. Evidence of BKPyV replication was assessed by viral quantification of blood and urine samples of studied patients using a quantitative real‐time polymerase chain reaction (Q‐PCR)PCR), detection of decoy cells in urine cytology smears, histological examination of graft biopsies from Q‐PCR BKPyV‐positive patients, and immunohistochemical staining by simian virus 40 (SV40) antibody.Results: Significant BKPyV infection was prevalent in 8% (n = 11) of our patients, with a peak of BKPyV infection about 8 months post transplant. BKPyV viral load by Q‐PCR assay in these patients varied from 1350 to 20,000,000 (1.35 × 103 to 2 × 107) copies/mL for urine samples and 935 to 18,920 (9.35 × 102 to 1.89 × 104) copies/mL for blood samples. All the 11 patients were positive for decoy cells but only 3 developed PVN based on histology and positive SV40 staining. BKPyV infection was more prevalent in older patients. All patients responded to reduction in their immunosuppressive regimens, apart from 2 patients who required replacement of calcineurin inhibitors‐based regimen with mammalian target of ramapycin inhibitors with an overall good response.Conclusion: Protocol screening programs based on detection of viral replication by viruria, viremia, and decoy cells in urine are necessary to shed light on patients with high virus replication and hence increased risk of developing PVN, and to allow early diagnosis and intervention.


  • Open Access

    The role of BCL-2 and BAK genes in chronic kidney disease and haemodialysis patients

    by Hanan Nour, Nariman Zahran, Samah Abd Elhamid, Manal Zahran, Manar Raafat, Asmaa El Saeed


  • Open Access

    Expression of IL4 (VNTR intron 3) and IL10 (-627) Genes Polymorphisms in Childhood Immune Thrombocytopenic Purpura

    by Manal Mohamed Makhlouf, Samah Mohamed Abd Elhamid

    Immune thrombocytopenic purpura (ITP) is an acquired autoimmune disorder caused by the production of antiplatelet antibodies. These autoantibodies opsonize platelets for splenic clearance, resulting in low levels of circulating platelets. Interleukin 4 (IL4) and interleukin 10 (IL10) are important immunoregulatory cytokines mainly produced by macrophages, monocytes, T cells, B cells, and mast cells. Our study was aimed at detecting the frequency of IL4 (VNTR intron 3) and IL 10 (-627) gene polymorphisms in Egyptian ITP children as genetic markers for ITP risk and clarifying their possible role in the pathogenesis of ITP as well as their correlation with the clinical presentation and laboratory data. IL4 (VNTR intron 3) and IL10 (-627) gene polymorphisms were studied in 70 ITP patients and 50 age- and sex-matched healthy controls using polymerase chain reaction-restriction fragment length polymorphism assay (PCR-RFLP). IL4 RP2 and IL10 A alleles were detected more frequently among ITP patients compared to controls. A statistically significant difference was observed in IL10 and IL4 gene polymorphism distribution between acute and chronic ITP patients, with higher A allele and RP2 allele among chronic ITP patients versus acute ITP patients. Combined polymorphisms of IL4 and IL10 genes were associated with greater risk of ITP. IL4 and IL10 gene polymorphisms may contribute to susceptibility for ITP in children.


  • Open Access

    A Study of Hepcidin and Monocyte Chemoattractant Protein‐1 in Egyptian Females With Systemic Lupus Erythematosus

    by Moataz Fatthy Mohammed, Dawlat Belal, Seham Bakry, Mohamed A. Marie, Laila Rashed, Reham Emad Eldin, Samah Abd El‐Hamid

    Background: Lupus nephritis is one of the most serious manifestations of systemic lupus erythematosus (SLE). Novel biomarkers are necessary to enhance the diagnostic accuracy, prognostic stratification, monitoring of treatment response, and detection of early renal flares.Methods: Our study was conducted on 90 participants. They were divided into three groups, group I (controls) encompassed 30 ages and sex‐matched healthy personnel. Group II included 30 non‐nephritic SLE patients and finally group III included 30 SLE nephritic patients. Urinary monocyte chemoattractant protein‐1 (UMCP‐1) and hepcidin were evaluated by ELISA technique, compared and correlated in different groups, with each other and with other routine variables and with renal biopsy done to study group (III).Results: Both UMCP‐1 and hepcidin in group III showed significant increase compared to other two groups (controls and group II) (468 ± 128, 111 ± 12, 252 ± 56 pg/ml, respectively, for UMCP‐1 and 40 ± 12, 11 ± 2, 20 ± 5 ng/ml, respectively, for hepcidin, P < 0.01). Also both UMCP‐1 and hepcidin in group III showed significant increase in diffuse proliferative subgroup compared to focal proliferative and mesangioproliferative subgroups (580 ± 43, 502 ± 46, and 352.6 ± 100 pg/ml, respectively, for UMCP‐1 and 47.8 ± 9.5, 41.4 ± 6, and 32.9 ± 10.8 ng/ml, respectively, for urinary hepcidin, P < 0.05).Conclusion: UMCP‐1 and hepcidin could be associated with the susceptibility of lupus nephritis.


  • P2Y12 receptor gene polymorphism and antiplatelet effect of clopidogrel in patients with coronary artery disease after coronary stenting

    by Naguib Zoheir, Samah Abd Elhamid, Nelly Abulata, Mehry El. Sobky, Doaa Khafagy, Amr Mostafa

    Platelets have a central role in the pathophysiology of thrombosis. Adenosine diphosphate (ADP) plays a pivotal role as an agonist of platelet activation. Genetic polymorphisms of the P2Y12 ADP receptor might influence the activation of this receptor by ADP or the response of patients to platelet inhibitors. The present study was conducted on a total number of 80 participants, 40 patients were diagnosed with acute coronary syndrome and 40 sex and aged-matched healthy volunteers were included as controls. Platelet aggregation was assessed (before and 1 week after clopidogrel administration) and genotyping of the T744C genetic polymorphism of P2Y12 receptor gene was carried out using the restriction fragment length polymorphism polymerase chain reaction (PCR-RFLP) method. Platelet aggregation of the patients had a range of 54-183% before clopidogrel administration and had a range of 4-113% after its administration. Genotyping of the candidate gene revealed that 72.5% of the patients had a wild allele (TT), whereas 27.5% had a C allele (heterozygous CT, homozygous CC). On the contrary, 97.5% of controls had a wild allele (TT), whereas 2.5% had a C allele (heterozygous CT, homozygous CC). Our study elicited an association between the T744C polymorphism of the P2Y12 ADP receptor gene and platelet reactivity. Carrying the C allele at this position is associated with an increased platelet activation response to ADP.